Research programme: HIV antibodies - PlantForm
Latest Information Update: 16 Jul 2016
At a glance
- Originator PlantForm Corporation
 - Class Antibodies
 - Mechanism of Action HIV fusion inhibitors
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity Yes
 - Available For Licensing Yes
 
Highest Development Phases
- No development reported HIV infections
 
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in HIV-infections in Canada (Parenteral)
 - 12 Aug 2013 PlantForm Corporation receives grant from the National Research Council of Canada Industrial Research Assistance Program for plant-produced antibody development in HIV infections
 - 06 May 2013 Research programme: HIV antibodies - PlantForm is available for licensing as of 17 Apr 2013. http://www.plantformcorp.com/